Neurosense Therapeutics Ltd (NRSN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.21M
Last updated: Nov 17, 2026 at 4:00 PM ET
Neurosense Therapeutics Ltd (NRSN) Stock Chart
Neurosense Therapeutics (NRSN) closed at $1.51 on Nov 17, 2026, 94.1% below its 52-week high of $25.40. Its price fell 92.3% over the past 12 months. The month-end price fell 78.4% over the 3 years through Oct 2026, a compound annual decline of 40.0%.
Price Chart
From Dec 2021 to Oct 2026, its highest month-end close was $79.40 in Mar 2022 and its lowest $1.99 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NRSN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NRSN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 81.0%, and over 6 months it fell 90.1%.
| Period | Change |
|---|---|
| 1 month | -43.3% |
| 3 months | -81.0% |
| 6 months | -90.1% |
| 12 months | -92.3% |
| 12 months, with dividends | -92.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -78.4% | -40.0% |
Price by Year
Its best calendar year was 2024, when the price rose 52.9%, and its weakest was 2022, when it fell 50.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.99 | -87.1% |
| 2025 | $15.38 | -35.9% |
| 2024 | $24.00 | +52.9% |
| 2023 | $15.70 | -35.7% |
| 2022 | $24.40 | -50.4% |
Trading Range
The price is 60.6% below its 50-day average of $3.83 and 87.2% below its 200-day average of $11.83.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 17, 2026) | $1.51 | |
| 52-week high | $25.40 | -94.1% |
| 52-week low | $1.10 | +37.3% |
| 50-day average | $3.83 | -60.6% |
| 200-day average | $11.83 | -87.2% |
Price Risk
Over 3 years, its largest fall from a peak was 97.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.62 |
| Largest fall, 1 year | -94.8% |
| Largest fall, 3 years | -97.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NRSN
What is NRSN's 1-year price change?
Neurosense Therapeutics's price fell 92.3% over the past 12 months. With dividends included, the 12-month total return was -92.3%.
How has NRSN stock done over the long term?
Neurosense Therapeutics's month-end price fell 78.4% over the 3 years through Oct 2026, a compound annual decline of 40.0%. These figures leave out dividends.
What is NRSN's 52-week high and low?
Neurosense Therapeutics's 52-week high is $25.40 and its 52-week low is $1.10. Its close of $1.51 on Nov 17, 2026 is 94.1% below the high.
What is NRSN's beta?
Neurosense Therapeutics's 1-year beta against the S&P 500 is 1.62, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 94.8%.
Is the NRSN chart free?
Yes. Advanced Charting for NRSN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NRSN pages: Overview, Charting, Financials